Original Research

Published on 02 May 2024

Predictive value of PD-L1 and TMB for short-term efficacy prognosis in non-small cell lung cancer and construction of prediction models

in Cancer Immunity and Immunotherapy

Shuling Shi
Yingyi Wang
Jingjing Wu
Boya Zha
Peihong Li
Yukun Liu
Yuchuan Yang
Jinglin Kong
Shibo Gao
Haiyang Cui

Frontiers in Oncology

doi 10.3389/fonc.2024.1342262

1,149 views

Original Research

Published on 01 May 2024

High immune cell infiltration predicts improved survival in cholangiocarcinoma

in Cancer Immunity and Immunotherapy

Erkki-Ville Wirta
Säde Szeto
Hanna Koppatz
Arno Nordin
Heikki Mäkisalo
Johanna Arola
Jukka Sirén
Maarit Ahtiainen
Jan Böhm
Jukka-Pekka Mecklin

Frontiers in Oncology

doi 10.3389/fonc.2024.1333926

1,152 views
1 citation

Original Research

Published on 29 Apr 2024

Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence

in Cancer Immunity and Immunotherapy

Diana C. Lopez
Kellsye P. Fabian
Michelle R. Padget
Yvette L. Robbins
Joshua T. Kowalczyk
Wiem Lassoued
Danielle M. Pastor
Clint T. Allen
Gary L. Gallia
James L. Gulley

Frontiers in Oncology

doi 10.3389/fonc.2024.1376622

1,690 views

Editorial

Published on 15 Apr 2024

Editorial: Emerging learnings in cell therapy: novel binding domains, universal CAR-T cells, and more

in Cancer Immunity and Immunotherapy

Anand Rotte

Frontiers in Oncology

doi 10.3389/fonc.2024.1404376

694 views

Review

Published on 10 Apr 2024

The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Yan Lu
Bo Lin
Mengsen Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1363695

1,870 views
3 citations

Case Report

Published on 05 Apr 2024

Retreatment with immunotherapy in a patient with hepatocellular carcinoma who received immune checkpoint inhibitors after primary curative treatment: a case report

in Cancer Immunity and Immunotherapy

Tao Wang
Fei Tang
Fenghui Li
Weili Yin
Jing Liang

Frontiers in Oncology

doi 10.3389/fonc.2024.1321195

882 views

Original Research

Published on 03 Apr 2024

VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma

in Cancer Immunity and Immunotherapy

Aida Jlassi
Rim Rejaibi
Maroua Manai
Ghada Sahraoui
Fatma Zahra Guerfali
Lamia Charfi
Amel Mezlini
Mohamed Manai
Karima Mrad
Raoudha Doghri

Frontiers in Oncology

doi 10.3389/fonc.2024.1352053

1,268 views

Systematic Review

Published on 03 Apr 2024

Comparative efficacy and safety of targeted therapy and immunotherapy for HER2-positive breast cancer: a systematic review and network meta-analyses

in Cancer Immunity and Immunotherapy

Suyu Gu
Yuting Liu
Yufan Huang
Wenzheng Lin
Ke Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1331055

1,429 views

Case Report

Published on 28 Mar 2024

Optimal response to tislelizumab plus chemotherapy in metastatic triple-negative breast cancer: a case report and literature review

in Cancer Immunity and Immunotherapy

Yuxin Ma
Xinhong Shi
Kun Zhao
Shuyi Hu
Yue Shi
Yingying Jiang
Yiling Liu
Lin Lu
Yuting Chang
Fei Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1328844

1,322 views

Study Protocol

Published on 28 Mar 2024

FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

in Cancer Immunity and Immunotherapy

Christopher Hackenbruch
Jens Bauer
Jonas S. Heitmann
Yacine Maringer
Annika Nelde
Monika Denk
Lisa Zieschang
Christine Kammer
Birgit Federmann
Susanne Jung

Frontiers in Oncology

doi 10.3389/fonc.2024.1367450

2,267 views
1 citation

Case Report

Published on 27 Mar 2024

Resection of unresectable hepatocellular carcinoma after conversion therapy with apatinib and camrelizumab: a case report and literature review

in Cancer Immunity and Immunotherapy

Xin-Liang Liu
Xiang-Ze Li
Yi-Fu Chu
Feng Liu
Hu Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1280805

1,175 views

Review

Published on 26 Mar 2024

Research progress of immunotherapy against anaplastic thyroid cancer

in Cancer Immunity and Immunotherapy

Jiaqian Chen
Zuixuan Xiao
Hongyan Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1365055

2,163 views

Review

Published on 20 Mar 2024

Prospects and challenges of CAR-T cell therapy combined with ICIs

in Cancer Immunity and Immunotherapy

Yufan Lv
Xinyu Luo
Zhuoyi Xie
Jieya Qiu
Jinsai Yang
Yuqi Deng
Rou Long
Guiyang Tang
Chaohui Zhang
Jianhong Zuo

Frontiers in Oncology

doi 10.3389/fonc.2024.1368732

2,831 views
5 citations

Case Report

Published on 14 Mar 2024

Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report

in Cancer Immunity and Immunotherapy

Claire V. Ong
Wolfram Samlowski

Frontiers in Oncology

doi 10.3389/fonc.2024.1301424

1,462 views
1 citation

Original Research

Published on 14 Mar 2024

Machine learning models based on quantitative dynamic contrast-enhanced MRI parameters assess the expression levels of CD3+, CD4+, and CD8+ tumor-infiltrating lymphocytes in advanced gastric carcinoma

in Cancer Immunity and Immunotherapy

Huizhen Huang
Zhiheng Li
Dandan Wang
Ye Yang
Hongyan Jin
Zengxin Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1365550

1,129 views
1 citation

Review

Published on 13 Mar 2024

Animal model considerations for chordoma research: reproducing the tumor microenvironment in vivo with humanized mice

in Cancer Immunity and Immunotherapy

Beatrice Campilan
Christian Schroeder
Emilija Sagaityte
Jonathan Arditi
Owen P. Leary
Ziya L. Gokaslan
Patricia L. Zadnik Sullivan
Margot Martinez-Moreno

Frontiers in Oncology

doi 10.3389/fonc.2024.1330254

1,584 views
1 citation

Navigation group

Articles

Predictive value of PD-L1 and TMB for short-term efficacy prognosis in non-small cell lung cancer and construction of prediction models

High immune cell infiltration predicts improved survival in cholangiocarcinoma

Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence

Editorial: Emerging learnings in cell therapy: novel binding domains, universal CAR-T cells, and more

The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma

Retreatment with immunotherapy in a patient with hepatocellular carcinoma who received immune checkpoint inhibitors after primary curative treatment: a case report

VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma

Comparative efficacy and safety of targeted therapy and immunotherapy for HER2-positive breast cancer: a systematic review and network meta-analyses

Optimal response to tislelizumab plus chemotherapy in metastatic triple-negative breast cancer: a case report and literature review

FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

Resection of unresectable hepatocellular carcinoma after conversion therapy with apatinib and camrelizumab: a case report and literature review

Research progress of immunotherapy against anaplastic thyroid cancer

Prospects and challenges of CAR-T cell therapy combined with ICIs

Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report

Machine learning models based on quantitative dynamic contrast-enhanced MRI parameters assess the expression levels of CD3+, CD4+, and CD8+ tumor-infiltrating lymphocytes in advanced gastric carcinoma

Animal model considerations for chordoma research: reproducing the tumor microenvironment in vivo with humanized mice